Skip to main content

Akdamar Erol R's Form 4 filing

HCA Healthcare, Inc. (HCA) · filed Feb 6, 2023

Accession no.
0001209191-23-007354
Filed
Feb 6, 2023
Trade date
Feb 2-3, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $775.9K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Akdamar Erol RCIK 0001957739Officer (Group President)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2023Common StockSSaleDisposed−3,000$258.63−$775,89034,726Direct
Feb 3, 2023Common StockMOption exerciseAcquired+9,000$45.30+$407,70043,726Direct
Feb 3, 2023Common StockFTax withholdingDisposed−3,932$258.08−$1,014,770.5639,794Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 3, 2023Common StockMOption exerciseDisposed−9,000$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)